Clostridioides Difficile Infection Flashcards

1
Q

How is C. Diff transmitted from person to person?

A

Through the fecal-oral route

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Risk factors for C. diff infection

A

-Antibiotic exposure
-Healthcare exposure
-Age over 65
-Proximity to a person with a C. diff infection
-Use of acid suppressing agents (PPI, H2RA)
-Chemotherapy
-Immunosuppression
-GI injury

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Which antibiotics increase the risk for C. diff?

A

-FQs
-Clindamycin
-Third and fourth generation cephalosporins
-Carbapenems

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Two primary symptoms of C. diff

A

-Profuse, watery or mucoid green, foul-smelling diarrhea
-Abdominal pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

When should you test for C. diff infection?

A

3 or more profuse, watery or mucoid green, foul-smelling stools in 24 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Three tests used for C. diff

A

-Nucleic acid amplification test (NAAT) alone (in conjunction with signs/symptoms)
-Antigen test (GDH) + toxin A/B test (NAAT used to resolve discordant results)
-NAAT + Toxin A/B test

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How would you define non-severe C. diff infection?

A

-WBC less than or equal to 15,000
-SCr less than 1.5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How would you define severe C. diff infection?

A

-WBC over 15,000
-SCr over 1.5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How would you define fulminant C. diff infection?

A

-Hypotension or shock
-Ileus
-Toxic megacolon (medical emergency)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Treatment options for C. diff infections

A

-Oral vancomycin
-Fidaxomicin
-Metronidazole (only used for fulminant cases as additional agent)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Considerations for oral vancomycin

A

-4x daily dosing
-Liquid version has bitter taste
-Low cost and typically covered by insurance (liquid version more costly)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Considerations for fidaxomicin

A

-Twice daily dosing
-Higher rates of sustained treatment response and lower recurrence rates when compared to vancomycin
-It is very expensive but insurance coverage is increasing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Considerations for metronidazole

A

-Good oral absorption (bad because we want it to stay in the stomach)
-Three times daily dosing
-Less efficacious and higher risk of recurrence
-Least costly option
-Last-line treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What medication should be avoided in C. diff patients?

A

Loperamide or any peristaltic agents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the treatment approach to recurrent CDI?

A

-Change the drug or dosing regimen
-Fidaxomicin extended dosing regimen
-Vancomycin tapered and pulsed dosing regimen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Treatment for fulminant CDI

A

-Vancomycin PO + metronidazole IV
-If ileus present, consider rectal vancomycin

17
Q

Risk factors for CDI recurrence

A

-Age 65 or more
-Severe CDI on presentation
-Immunocompromised host

18
Q

What is a fecal microbiota transplant (FMT)?

A

-Administration of fecal material from healthy person to restore a balanced gut microbiome
-Utilized as both a treatment option and method to reduce recurrence

19
Q

What are possible indications for FMT?

A

-Three or more episodes of CDI
-Poor response to initial antibiotic therapy for CDI

20
Q

How are FMTs administered?

A

Requires administration via endoscopy, colonoscopy, or rectal tube

21
Q

What is Rebyota?

A

-Fecal microbiota suspension
-Administered via rectal tube

22
Q

What is Vowst?

A

-Bacterial spore suspension
-Administered via oral route

23
Q

What is bezlotoxumab?

A

-Monoclonal antibody targeting C. diff toxin B to neutralize its effect
-Potentially increased risk of CHF and mortality
-Prevents CDI recurrence for patients at high risk